- call +1-201-465-4211
- email sales@mrinsights.biz
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
Scope of the Report:
The classification of Allergy Immunotherapy includes Subcutaneous Immunotherapy and Sublingual Immunotherapy. The proportion of Subcutaneous Immunotherapy in 2017 is about 55.1%, and the proportion of Sublingual Immunotherapy in 2016 is about 44.9%.
Allergy Immunotherapy are application in Allergic Rhinitis, Allergic Asthma and Other. The most of Allergy Immunotherapy is used in Allergic Rhinitis, and the market share of that is about 45.3 % in 2017.
Europe is the largest consumption place, with a consumption market share nearly 68.5% in 2017, Allergy is the most common chronic disease in Europe. Up to 20% of patients with allergies struggle daily with the fear of a possible asthma attack, anaphylactic shock, or even death from an allergic reaction. Following Europe, North America is the second largest consumption place with the consumption market share of 19.2% in 2017. Allergy Immunotherapy market in Asia Pacific region is expected to exhibit the highest growth rate due to high incidence of allergy people in the developing Asian countries like China & India.
Market competition is intense. ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, etc. are the leaders of the industry with the market share is about 76.6% in 2017.
The global Allergy Immunotherapies (Allergy Immunotherapy) market is valued at 1070 million USD in 2018 and is expected to reach 1890 million USD by the end of 2024, growing at a CAGR of 9.9% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Allergy Immunotherapies (Allergy Immunotherapy).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Allergy Immunotherapies (Allergy Immunotherapy) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Allergy Immunotherapies (Allergy Immunotherapy) market by product type and applications/end industries.
Market Segment by Companies, this report covers
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Market Segment by Applications, can be divided into
Allergic Rhinitis
Allergic Asthma
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Allergy Immunotherapies (Allergy Immunotherapy) Market Overview
1.1 Product Overview and Scope of Allergy Immunotherapies (Allergy Immunotherapy)
1.2 Classification of Allergy Immunotherapies (Allergy Immunotherapy) by Types
1.2.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Revenue Comparison by Types (2019-2024)
1.2.2 Global Allergy Immunotherapies (Allergy Immunotherapy) Revenue Market Share by Types in 2018
1.2.3 Subcutaneous Immunotherapy
1.2.4 Sublingual Immunotherapy
1.3 Global Allergy Immunotherapies (Allergy Immunotherapy) Market by Application
1.3.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Global Allergy Immunotherapies (Allergy Immunotherapy) Market by Regions
1.4.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Allergy Immunotherapies (Allergy Immunotherapy) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Allergy Immunotherapies (Allergy Immunotherapy) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Allergy Immunotherapies (Allergy Immunotherapy) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Allergy Immunotherapies (Allergy Immunotherapy) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Allergy Immunotherapies (Allergy Immunotherapy) Status and Prospect (2014-2024)
1.5 Global Market Size of Allergy Immunotherapies (Allergy Immunotherapy) (2014-2024)
2 Manufacturers Profiles
2.1 ALK-Abello
2.1.1 Business Overview
2.1.2 Allergy Immunotherapies (Allergy Immunotherapy) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ALK-Abello Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2018)
2.2 Stallergenes Greer
2.2.1 Business Overview
2.2.2 Allergy Immunotherapies (Allergy Immunotherapy) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Stallergenes Greer Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck
2.3.1 Business Overview
2.3.2 Allergy Immunotherapies (Allergy Immunotherapy) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2018)
2.4 Allergy Therapeutics
2.4.1 Business Overview
2.4.2 Allergy Immunotherapies (Allergy Immunotherapy) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Allergy Therapeutics Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2018)
2.5 HAL
2.5.1 Business Overview
2.5.2 Allergy Immunotherapies (Allergy Immunotherapy) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 HAL Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2018)
2.6 WOLW Pharma
2.6.1 Business Overview
2.6.2 Allergy Immunotherapies (Allergy Immunotherapy) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 WOLW Pharma Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2018)
2.7 Holister Stier
2.7.1 Business Overview
2.7.2 Allergy Immunotherapies (Allergy Immunotherapy) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Holister Stier Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2018)
2.8 Leti
2.8.1 Business Overview
2.8.2 Allergy Immunotherapies (Allergy Immunotherapy) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Leti Allergy Immunotherapies (Allergy Immunotherapy) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Competition, by Players
3.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Allergy Immunotherapies (Allergy Immunotherapy) Players Market Share
3.2.2 Top 10 Allergy Immunotherapies (Allergy Immunotherapy) Players Market Share
3.3 Market Competition Trend
4 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size by Regions
4.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Market Share by Regions
4.2 North America Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
4.3 Europe Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
4.5 South America Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
5 North America Allergy Immunotherapies (Allergy Immunotherapy) Revenue by Countries
5.1 North America Allergy Immunotherapies (Allergy Immunotherapy) Revenue by Countries (2014-2019)
5.2 USA Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
5.3 Canada Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
5.4 Mexico Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
6 Europe Allergy Immunotherapies (Allergy Immunotherapy) Revenue by Countries
6.1 Europe Allergy Immunotherapies (Allergy Immunotherapy) Revenue by Countries (2014-2019)
6.2 Germany Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
6.3 UK Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
6.4 France Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
6.5 Russia Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
6.6 Italy Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Allergy Immunotherapies (Allergy Immunotherapy) Revenue by Countries
7.1 Asia-Pacific Allergy Immunotherapies (Allergy Immunotherapy) Revenue by Countries (2014-2019)
7.2 China Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
7.3 Japan Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
7.4 Korea Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
7.5 India Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
8 South America Allergy Immunotherapies (Allergy Immunotherapy) Revenue by Countries
8.1 South America Allergy Immunotherapies (Allergy Immunotherapy) Revenue by Countries (2014-2019)
8.2 Brazil Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
8.3 Argentina Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
8.4 Colombia Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Allergy Immunotherapies (Allergy Immunotherapy) by Countries
9.1 Middle East and Africa Allergy Immunotherapies (Allergy Immunotherapy) Revenue by Countries (2014-2019)
9.2 Saudi Arabia Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
9.3 UAE Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
9.4 Egypt Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
9.5 Nigeria Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
9.6 South Africa Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Growth Rate (2014-2019)
10 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Segment by Type
10.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Revenue and Market Share by Type (2014-2019)
10.2 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Forecast by Type (2019-2024)
10.3 Subcutaneous Immunotherapy Revenue Growth Rate (2014-2024)
10.4 Sublingual Immunotherapy Revenue Growth Rate (2014-2024)
11 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Segment by Application
11.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Revenue Market Share by Application (2014-2019)
11.2 Allergy Immunotherapies (Allergy Immunotherapy) Market Forecast by Application (2019-2024)
11.3 Allergic Rhinitis Revenue Growth (2014-2019)
11.4 Allergic Asthma Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size Forecast (2019-2024)
12.1 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Size Forecast (2019-2024)
12.2 Global Allergy Immunotherapies (Allergy Immunotherapy) Market Forecast by Regions (2019-2024)
12.3 North America Allergy Immunotherapies (Allergy Immunotherapy) Revenue Market Forecast (2019-2024)
12.4 Europe Allergy Immunotherapies (Allergy Immunotherapy) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Allergy Immunotherapies (Allergy Immunotherapy) Revenue Market Forecast (2019-2024)
12.6 South America Allergy Immunotherapies (Allergy Immunotherapy) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Allergy Immunotherapies (Allergy Immunotherapy) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Allergy Immunotherapies (Allergy Immunotherapy) Picture
Table Product Specifications of Allergy Immunotherapies (Allergy Immunotherapy)
Table Global Allergy Immunoth
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
